ROCKVILLE, Md. (AP) — ROCKVILLE, Md. (AP) — Supernus Pharmaceuticals Inc. (SUPN) on Thursday reported profit of $20.9 million in its third quarter.
On a per-share basis, the Rockville, Maryland-based company said it had profit of 35 cents. Earnings, adjusted for amortization costs and stock option expense, were 93 cents per share.
The drugmaker posted revenue of $226.8 million in the period.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on SUPN at https://www.zacks.com/ap/SUPN
